Rahul Shahani

Thanks for the very kind words Sommos! The firm's mission of modernizing and digitizing traditional financial structures like ROSCA to better serve individual's needs and strengthening #financialinclusion is very needed. Its a privilege to help any way I can. #techstars #payments #fintech

44

1 Comment

I’m happy to share a recent report from BCG on how patient analytics can play a crucial role in improving #healthequity. The report focuses on the significant disparities in treatment outcomes for Heart Failure with Reduced Ejection Fraction (HFrEF). The study reveals critical gaps, particularly in urban underserved areas, calling for urgent and strategic interventions. Read the report to learn about key actions #healthcare leaders can take to improve #healthequity: https://lnkd.in/euzj3tzW

17

Explore Deloitte’s report (authored by 3 of my esteemed colleagues) to learn how 3 #CellAndGene therapy pricing models could help transform how CGT therapies are financed. https://deloi.tt/3RE72Lm

10

Check out my BCG colleagues recent report that focuses on improving #healthequity with patient analytics. The research unveils significant disparities in the treatment of Heart Failure with Reduced Ejection Fraction (HFrEF) across the United States. Focusing on areas with notably low engagement, particularly in under-served urban areas. Explore the findings and actionable strategies here: https://lnkd.in/ec-GHthB

7

FTI Consulting's Jason Shafrin,PhD, and Jaehong Kim, PhD, have published an innovative study that reimagines how we evaluate healthcare technologies and treatments. Our new Generalized Cost-Effectiveness Analysis (GCEA) framework goes beyond traditional metrics to consider 15 key value elements that matter to society, including: -How treatments affect patient confidence and risk -Long-term benefits as treatments evolve -Impact on caregivers and communities -Broader societal benefits like workplace productivity Why this matters: Current methods often miss important benefits of new healthcare technologies. Our user guide makes it easier to capture these broader impacts, leading to better-informed healthcare decisions. Read our complete framework and user guide below. #Healthcare #HealthEconomics #ValueBasedCare #FTIConsulting #Research #HealthcareInnovation

1

BCG Roundtable Focused on Key Trends Shaping the Future of Clinical Operations   Was thrilled to host an energetic discussion at our inaugural Clinical Operations roundtable earlier this week with industry executives across biopharma to discuss the most pressing topics shaping these teams. Thank you to our BCG team that enabled this discussion John Wu, Najaf A. Shah Shah, Paul Hastwell, Deming Qin Rachel Magid Beatriz Monedero Álvarez. Four Key Trends from the Roundtable: 1. Simplifying Protocols to Improve Patient-Centricity and Equity Growing emphasis on reducing patient burden during clinical trials is reshaping clinical operations and clinical trial decision-making more broadly. Companies are leveraging data and analytics to design smarter, more inclusive trials while simplifying protocols for patients and sites. They are also bringing in patients to shape their protocols 2. Continuing to Accelerate Trial Timelines Site Activation and patient enrolment remain critical bottlenecks and a key discussion point, with participants sharing the strategies and initiatives they are pursuing (e.g., trial footprint and site mix adjustments, digital recruitment approaches and evolving site facing roles) to deliver trials faster. 3. Evolving Sourcing Models: To boost efficiency and capacity, companies are rethinking resource allocation, exploring more offshoring and functional service provider (FSP) to manage capacity; Full-service outsourcing (FSO) models still have a role, particularly for mid-sized companies and select studies 4. Harnessing (Gen)AI: GenAI is revolutionizing trial operations, from AI-powered design tools, automated document generation and dashboards to decentralized research and patient engagement. These innovations are set to enhance trial delivery and patient experience. Exciting times for Clinical Operations teams as they play a critical role in bringing medicines to patients faster in a cost-effective and efficient manner, with greater consideration of the patient experience and needs. To join us in future discussions, please get in touch at ClinDevOps@bcg.com #clinical, #trials, #GenAI

79

5 Comments

Abhinav is our global head of AI - here with some interesting practical tips here for those that are getting into it.

18

AI has the potential to transform patient care delivery and life sciences innovation. Our team at Boston Consulting Group (BCG) and Massachusetts High Technology Council – in collaboration with leaders from industry, hospitals, and academia – examined AI’s impact on healthcare and life sciences. Our whitepaper articulates a strategy to establish Massachusetts as the global leader in “applied” AI within these sectors, using AI to improve patient outcomes, promote health equity, and advance breakthrough innovation.   Read more about the recommendations and the future of healthcare here:

5

Aneesh Chopra, Arcadia chief strategy officer and former U.S. chief technology officer, joins Resonant Principal Robin Weinick and Guidehouse Director Don Simpson to discuss leveraging AI and data to capture the full potential of value-based models. The experts also examine the role of social determinants of health data in helping to improve population health and lower healthcare costs. Listen to the Keeping IT Brief podcast.

3

My colleagues, Val Panier, together with John Wu, Nithya Vaduganathan, Vladimir Lukic, Margot Bleys, and in partnership with the Massachusetts High Technology Council, Inc. recently released a white paper outlining actionable recommendations to leverage AI for advancing the state’s life sciences and #healthcare sectors. The state of Massachusetts is making significant strides to become a leader in artificial intelligence. The potential for AI in healthcare is immense. Our report details a strategic approach to utilizing AI to improve patient outcomes, promote health equity, and accelerate breakthrough innovations. Learn more here: https://lnkd.in/em_EyTjw

67

2 Comments

My colleagues, Eric Berger, Robbie Sandig, and KC George shares how large and small pharma companies are succeeding with generative AI and the three-tiered approach guiding them to the forefront. Key takeaways include the importance of priming operating models and leveraging scale for breakthroughs.

3

1 Comment

Hot off the presses --- Global #Healthcare #PrivateEquity -- Bain's 2025 Global Healthcare Private Equity Report is here! Our experts dive into key industry trends driving deal activity, including sellers' increased focus on showcasing equity value-creation potential, buyers leveraging carve-outs to sustain deal volume, growing interest among dealmakers in Asia-Pacific opportunities, and the evolving investment strategies mid-market firms need to maintain strong performance. https://bit.ly/4j7dDu2

2

In this second part of the two-part discussion with Torsten Bernewitz, we dive into how to shape organizational structure and operating models to support patient centricity. Torsten discusses the need to break with traditional, and often successful, ways of operating, as well as the approaches and models organizations can adopt. Listen here: https://apple.co/3Vadyv9

8

GenAI’s potential in #healthcare extends across diagnostics, patient care, and beyond. Imagine AI-powered tools that streamline patient interactions, refine diagnosis, and optimize treatments—all while lowering costs. The tech is reshaping the value of care and patient outcomes in real time. Learn more: https://on.bcg.com/4fBW3f5

6

The past two years have been challenging for investors in the healthcare provider sector– but underlying trends that make provider investments attractive persist. Focusing on four capabilities—patient engagement, care delivery, productivity solutions, and new opportunities—could help spur performance and ensure long-term viability. Learn more in our latest McKinsey Healthcare Blog. ⬇️

25

What can we expect for US healthcare in 2025 and beyond? Excited to share new perspectives from my McKinsey & Company colleagues Shubham Singhal and Neha Patel on how industry economics are shifting. Non-acute care delivery, healthcare software, data, analytics, and specialty pharmacy are segments to watch in the year ahead. Read their full analysis here: https://lnkd.in/enrZGQG3 #healthcare #health #healthcaretrends

2

Everyone at every conference is talking about AI scribes these days. To provide a quick overview of the market, I partnered with my wonderful ECG Management Consultants colleagues Asif Shah Mohammed, Utpal Desai, and Thomas Guillaume on our latest blog post. More to come! https://lnkd.in/gFEfGxdF

27

1 Comment

Axios highlighted Bain analysis showing companies further accelerating reshoring and near-shoring amid heightened geopolitical uncertainties and rising costs. Hernan Saenz, head of Bain’s Performance Improvement practice, discussed the trend with Axios chief economics correspondent Neil Irwin. https://bit.ly/4fl5LSp

3